Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 44NET 1Endocrine 1

Conditions

Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Carcinoma, Hepatocellular 1

Interventions

Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2FAPI-46 2Everolimus 2regorafenib 1lanreotide 1gadoteridol 1gadoterate meglumine 1gadolinium ethoxybenzyl DTPA 1gadodiamide 1gadobutrol 1gadobenic acid 1exemestane 1Tirapazamine 1Surveys and Questionnaires 1Sorafenib 1Radiofrequency Ablation 1Quality of Life 1Octreotide 1Neuropsychological Tests 1Injections 1Ethiodized Oil 1E-7386 1Cytidine Triphosphate 1Cryotherapy 1Clinical Trials, Phase II as Topic 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Radiofrequency Ablation × NET × Clear all
NCT02973204 2021-04-28

Circulating Tumor Cells and Tumor DNA in HCC and NET

University of Aarhus

Completed
167 enrolled
EndocrineGastrointestinalNET

Carcinoma, Hepatocellular, Neoplastic Cells, Circulating, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡